We found that genes involved in the aberrant RNA splicing in GC (CD44), the RAS oncogene family (RAB5C, RANN), the TNF-α/NF-κB signaling pathway (e.g., NR4A2, TANK, PFKFB3), and the zinc finger protein family (e.g., ZNF74, ZNF671, ZNF106) were differentially spliced among GC samples with lower and higher risk scores (Figure 8C). This evidence concerns the gene CD44 and gastric cancer.